SANUWAVE Health (SNWV) Projected to Post Earnings on Thursday

SANUWAVE Health (OTCMKTS:SNWV) is expected to be issuing its results before the market opens on Thursday, March 19th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $13.2260 million for the quarter.

SANUWAVE Health Trading Down 1.0%

Shares of OTCMKTS:SNWV opened at $22.23 on Thursday. The firm’s 50 day moving average is $26.11 and its two-hundred day moving average is $31.02. The firm has a market capitalization of $190.64 million, a P/E ratio of 2.67 and a beta of 1.32. SANUWAVE Health has a 52 week low of $21.76 and a 52 week high of $46.58.

SANUWAVE Health Company Profile

SANUWAVE Health, Inc is a medical technology company focused on the development and commercialization of non‐invasive, extracorporeal shockwave therapy devices. Headquartered in Suwanee, Georgia, the company designs and markets its proprietary Pulse® technology platform, which delivers acoustic shockwaves to stimulate tissue regeneration and repair. SANUWAVE’s primary objective is to address chronic and hard-to-heal conditions across wound care and musculoskeletal indications by offering an alternative to surgical intervention.

The company’s flagship product, the PACE® (Pulse Activated Cell therapy) system, is intended for the treatment of diabetic foot ulcers and other types of chronic wounds.